Alzheimer's disease may be detectable by key blood test, study finds
Fox News
A new blood test may identify more than 80% of people with increased likelihood of having amyloid in the brain, a protein that’s a risk factor for developing Alzheimer’s disease
Because these plaques accumulate in patients’ brains before the signs and symptoms appear of Alzheimer’s disease, a positron emission tomography (PET) scan is traditionally ordered to identify those at most risk, according to a recent report.
C₂N Diagnostics, however, developed a blood test called PrecivityAD that accurately predicts the level of amyloid that was on a PET scan 81% of the time.
More Related News